OVERVIEW

Community Practice Connections™: A New Wave of Progress in Myelodysplastic Syndromes (MDSs): Optimizing Outcomes from Diagnosis to Treatment is organized by Physicians' Education Resource, LLC (PER).

Release Date: October 31, 2019
Expiration Date: October 31, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
A rapidly evolving treatment landscape and changes to prognostic scoring systems have created a practice gap for healthcare providers treating patients with myelodysplastic syndromes (MDSs). This online enduring activity will address challenges that clinicians face during the diagnostic process and accurate confirmation of MDS versus other causes of anemia. Case-based questions are incorporated into this program for participants to virtually apply the presented concepts, followed by videos of interviews with top experts in which they discuss the rationale behind the best answer option for each question. In addition, prominent experts discuss the latest data for management of high-risk and low-risk MDS for patients who are eligible for transplant and for those who are not, including treatment of MDS in older adults. Experts will discuss the implications for clinical practice as well as their own preferences and perspectives on clinical trial data in relation to daily practice.

This Community Practice Connection™ program will help clinicians meet the challenge of acquiring this knowledge through a series of video interviews with top experts in MDS on making an accurate diagnosis of MDS, best practices in risk stratification of patients with MDS, and overcoming commonly observed clinical challenges, as well as reviewing novel therapeutic options for differing levels of risk and patient characteristics.

Benefits of Participating:
• Increase knowledge and competence regarding diagnostic and prognostic assessment of MDS
• Learn strategies to effectively manage complex cases of low-risk and high-risk MDS within the context of best practices from leading experts in MDS
• Utilize real-world case examples provided by experts to support effective clinical decision making in your practice
• Build confidence in your knowledge of how to optimally treat older adults with MDS via incorporation of novel therapeutic strategies and agents into treatment planning
• Improve knowledge of best practice management of patients after treatment failure

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Review tools for MDS classification and risk stratification, based on morphological, clinical, and cytogenetic criteria
• Evaluate strategies for tailoring therapy for patients with MDS based on risk stratification and patient comorbidities in the frontline setting and beyond
• Translate clinical trial evidence into real-world practice for the management of MDS
• Assess data from recent clinical trials evaluating efficacy and safety of novel therapies and strategies for the treatment of patients with MDS